The Union of Religious of Flanders (URV) is urging victims of sexual abuse in Flemish congregations to file formal complaints. The call follows a VTM documentary series, 'De Nonnen' (The Nuns), whose ...

Federal employee unions on Tuesday asked a federal judge in California to stop the Trump administration from using plans for a mass firing of federal employees if there is a partial government ...

This is an edited transcript of an episode of “The Ezra Klein Show.” You can listen to the conversation by following or subscribing to the show on the NYT Audio app, Apple, Spotify, Amazon Music, ...

Windows 11’s September Patch Tuesday update, KB5065426, is reportedly breaking file and print sharing across networks. According to posts on the Microsoft Community forum, the latest update is ...

This fully updated volume explores a wide array of new and state-of-the-art tools and resources for protein function prediction. Beginning with in-depth overviews of essential underlying computational ...

Ever since I was a child, I’ve despised answering the phone when an unknown number calls. Who could be on the other end? Literally anyone: an acquaintance, a telemarketer, a serial killer who’s ...

Lisa Phillips outlined that some of the survivors "have been discussing creating our own list" of people within Epstein's orbit. "We know the names, many of us were abused by them," Phillips said.

Marina Lacerda was "Minor-Victim 1" in Epstein’s 2019 indictment, sources say. The woman who provided critical evidence that allowed federal prosecutors to charge Jeffrey Epstein with sex trafficking ...

Jake brings two decades of experience with him, having covered major industry events, breaking news, one-on-one interviews, and more. When he's not playing World of Warcraft, he's usually on the hunt ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The AJC has fallen short of the ...

While all publicly traded enterprises aim for business success, achieving it can also ironically lead to valuation pressures. That's the tough lesson that pharmaceutical giant Gilead Sciences, Inc.